Rebecca Hendrickson, MD, PhD
The Hendrickson research group explores underlying biological mechanisms related to the development and maintenance of posttraumatic stress disorder (PTSD) and related conditions, including mild traumatic brain injury, as well as the potential for interaction between different types of stress and trauma. Through the design and implementation of translational clinical studies, we apply this work directly to the pursuit of new treatment options for people who have experienced a traumatic stress.
A primary goal of our team is to understand broadly the ways traumatic stress interferes with people’s lives, and to prioritize the areas of greatest clinical need. We look for ways to prevent persistent symptoms after trauma, to match patients more quickly to the treatment options that will be most effective for them as individuals, and to develop new treatment options for those for whom current options are simply not adequate.
In addition to my research work, I am a staff psychiatrist in the VA PTSD Outpatient Clinic and a member of the VA Dialectical Behavioral Therapy (DBT) Team, and provide teaching and mentorship for residents in the UW Psychiatry Training Program.
Education
Research Fellowship in PTSD Clinical trials, VA Puget Sound, 2015-2018
Psychiatry Residency, University of Washington, 2010-2015
Medical School, Washington University in St. Louis, 2001-2010
PhD in Systems Neuroscience, Washington University in St. Louis, 2003-2008
Bachelors of Neurobiology and Biochemistry, University of Washington 1996-2001
Department Affiliations
Centers/Programs
Scholarly Expertise
- Event- related potential (ERP) as a biomarker for subtyping neurobiology of PTSD: A pilot study
- Biomarkers in the retina for prognosticating mental health treatments (BRIGHT)
- The PREDICT study: a personalized medicine approach to prazosin for PTSD
- The ATTEND study for Healthcare Workers and First Responders
- The RECOVER study: testing online platforms to identify patients with persistent post-COVID symptoms
- Improving resilience and recovery from traumatic events using the ECHO model
- Does the microbiome play a role in adverse outcomes following mTBI and PTSD?
Recent Publications
(2024 Oct 28)
Arch Clin Neuropsychol
Rau HK, Sheppard DP, Karr JE, Hendrickson RC, Schindler A, Peskind ER, Pagulayan KF
(2024 Oct 1)
Drug Alcohol Depend 263(): 112419
May AC, Hendrickson RC, Pagulayan KF, Schindler AG
(2023 Dec)
Sleep Med X 5(): 100067
Hendrickson RC, McCall CA, Rosser AF, Pagulayan KF, Chang BP, Sano ED, Thomas RG, Raskind MA
(2023 Feb)
Alcohol Clin Exp Res (Hoboken) 47(2): 348-360
Raskind MA, Williams T, Holmes H, Hart K, Crews L, Poupore EL, Thomas RG, Darnell J, Daniels C, Goke K, Hendrickson R, Terry G, Mayer C, Simpson T, Saxon A, Rasmussen D, Peskind ER
(2022 Oct 30)
medRxiv
Hendrickson RC, McCall CA, Rosser AF, Pagulayan KF, Chang BP, Sano ED, Thomas RG, Raskind MA
Show complete publication list »